Exergen TemporalScanner Outpaces Welch Allyn Oral/Rectal Thermometer for Pediatrician Preference
Oct 11, 2016 11:00 am UTC| Business
WATERTOWN, Mass., Oct. 11, 2016 -- A new study shows pediatricians ranked temporal artery thermometry (TAT) number one in overall preference over any other thermometry method and furthermore use and recommend the...
4th Annual Big Kahuna Wing Festival Sets Records!
Oct 11, 2016 11:00 am UTC| Business
KNOXVILLE, Tenn., Oct. 11, 2016 -- Tennessee’s largest annual chicken wing festival – the Big Kahuna Wing Festival presented by US Foods – took place on Saturday, June 11th from 12:00 p.m. to 8:00 p.m. at World’s Fair...
Oct 11, 2016 11:00 am UTC| Business
WESTLAKE VILLAGE, Calif., Oct. 11, 2016 -- Inspyr Therapeutics, Inc. (OTCQB:NSPX), a biotech company developing a novel prodrug therapeutic for the treatment of cancer, announced today the appointment of Michael Elliott...
Seabridge Gold Obtains Permits for Deep Kerr Exploration Adit
Oct 11, 2016 11:00 am UTC| Business
TORONTO, Oct. 11, 2016 -- Seabridge Gold Inc (TSX:SEA) (NYSE:SA) announced today it has received the permits from the BC Government necessary to develop an exploration adit into the large Deep Kerr Deposit at its...
Oct 11, 2016 11:00 am UTC| Business
SAINT-GENIS-POUILLY, France, Oct. 11, 2016 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (“AAA” or the “Company”), an international specialist in Molecular Nuclear Medicine (MNM), today announced that data...
BMC to Host 2016 Third Quarter Financial Results Conference Call and Webcast
Oct 11, 2016 11:00 am UTC| Business
ATLANTA, Oct. 11, 2016 -- BMC Stock Holdings, Inc. (Nasdaq:BMCH) (“BMC” or the “Company”), a leading provider of diversified lumber and building materials and solutions to new construction builders and remodeling...
Curis Expands Oncology Pipeline with an Oral Small Molecule PD-L1/TIM-3 Immune Checkpoint Antagonist
Oct 11, 2016 11:00 am UTC| Business
CA-327, a PD-L1/TIM3 dual antagonist designed and optimized by Aurigene, licensed as the 2nd oral small molecule immuno-oncology development candidate under the Curis Aurigene collaboration LEXINGTON, Mass., Oct. 11,...